+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Non-opioid Pain Patches Market by Patch Type (Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches), Indication (Arthritis, Back Pain, Fibromyalgia), Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5460257
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Non-opioid Pain Patches Market size was estimated at USD 701.29 million in 2023, USD 790.97 million in 2024, and is expected to grow at a CAGR of 12.88% to reach USD 1,637.77 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Non-opioid Pain Patches Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Non-opioid Pain Patches Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Non-opioid Pain Patches Market, highlighting leading vendors and their innovative profiles. These include Bridges Consumer Healthcare, LLC, Cardinal Health, Inc., Endo International plc, GlaxoSmithKline Plc., Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi S.A., SCILEX Pharmaceuticals Inc., Sorrento Therapeutics, Inc., Teh Seng Pharmaceutical Mfg. Co., Ltd., Teikoku Seiyaku Co. Ltd., Teva Pharmaceutical Industries Ltd., Veridian Healthcare, and Virpax Pharmaceuticals, Inc.

Market Segmentation & Coverage

This research report categorizes the Non-opioid Pain Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Patch Type
    • Capsaicin Patches
    • Diclofenac Patches
    • Ketoprofen Patches
    • Lidocaine Patches
    • Methyl Salicylate Patches
  • Indication
    • Arthritis
    • Back Pain
    • Fibromyalgia
    • Migraines & Headaches
    • Muscle Strain & Sprains
    • Post-Herpetic Neuralgia
  • Distribution
    • Drug Stores
    • Hospitals
    • Online Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Non-opioid Pain Patches Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Non-opioid Pain Patches Market?
  3. What are the technology trends and regulatory frameworks in the Non-opioid Pain Patches Market?
  4. What is the market share of the leading vendors in the Non-opioid Pain Patches Market?
  5. Which modes and strategic moves are suitable for entering the Non-opioid Pain Patches Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Non-opioid Pain Patches Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Chronic and Acute Pain-Related Disorders
5.1.1.2. Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
5.1.1.3. Benefits Associated with Non-opioid Pain Patches over Conventional Medications
5.1.2. Restraints
5.1.2.1. Limited Awareness Associated with Non-opioid Pain Patches
5.1.3. Opportunities
5.1.3.1. Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
5.1.3.2. Rising R&D in Pain Management Treatments
5.1.4. Challenges
5.1.4.1. Significant Side Effect Coupled with Availability of Alternative Treatments
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Non-opioid Pain Patches Market, by Patch Type
6.1. Introduction
6.2. Capsaicin Patches
6.3. Diclofenac Patches
6.4. Ketoprofen Patches
6.5. Lidocaine Patches
6.6. Methyl Salicylate Patches
7. Non-opioid Pain Patches Market, by Indication
7.1. Introduction
7.2. Arthritis
7.3. Back Pain
7.4. Fibromyalgia
7.5. Migraines & Headaches
7.6. Muscle Strain & Sprains
7.7. Post-Herpetic Neuralgia
8. Non-opioid Pain Patches Market, by Distribution
8.1. Introduction
8.2. Drug Stores
8.3. Hospitals
8.4. Online Pharmacies
9. Americas Non-opioid Pain Patches Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Non-opioid Pain Patches Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Non-opioid Pain Patches Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Bridges Consumer Healthcare, LLC
13.1.2. Cardinal Health, Inc.
13.1.3. Endo International plc
13.1.4. GlaxoSmithKline Plc.
13.1.5. Hisamitsu Pharmaceutical Co., Inc.
13.1.6. Johnson & Johnson Services, Inc.
13.1.7. Pfizer Inc.
13.1.8. Sanofi S.A.
13.1.9. SCILEX Pharmaceuticals Inc.
13.1.10. Sorrento Therapeutics, Inc.
13.1.11. Teh Seng Pharmaceutical Mfg. Co., Ltd.
13.1.12. Teikoku Seiyaku Co. Ltd.
13.1.13. Teva Pharmaceutical Industries Ltd.
13.1.14. Veridian Healthcare
13.1.15. Virpax Pharmaceuticals, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. NON-OPIOID PAIN PATCHES MARKET RESEARCH PROCESS
FIGURE 2. NON-OPIOID PAIN PATCHES MARKET SIZE, 2023 VS 2030
FIGURE 3. NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NON-OPIOID PAIN PATCHES MARKET DYNAMICS
FIGURE 7. NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2023 VS 2030 (%)
FIGURE 8. NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 12. NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. NON-OPIOID PAIN PATCHES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 6. NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 12. NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 19. NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 32. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 35. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 49. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 50. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 52. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 58. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 76. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 89. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 92. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 95. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 98. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 104. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 105. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 113. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 116. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 117. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 119. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 131. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 140. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 149. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 150. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 151. NON-OPIOID PAIN PATCHES MARKET LICENSE & PRICING

Companies Mentioned

  • Bridges Consumer Healthcare, LLC
  • Cardinal Health, Inc.
  • Endo International plc
  • GlaxoSmithKline Plc.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • SCILEX Pharmaceuticals Inc.
  • Sorrento Therapeutics, Inc.
  • Teh Seng Pharmaceutical Mfg. Co., Ltd.
  • Teikoku Seiyaku Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Veridian Healthcare
  • Virpax Pharmaceuticals, Inc.

Methodology

Loading
LOADING...

Table Information